Cure Ventures Management, LP
Emerging managerSEC exempt reporting adviser (venture capital exemption).
- Website
- https://www.curevc.com/
- HQ
- MA
Cure Ventures Management is a life sciences venture capital firm founded in 2021. It invests in new companies built around curative technologies. Its portfolio includes companies working on cancer medicines, autoimmune and inflammatory treatments, neurological therapies, and digital health care.
New fund likely raising soon
The firm's newest fund is 4 to 7 years past its first sale and no newer Form D has been filed.
01 · Says / Does
| Tag | Says | Does |
|---|---|---|
| Stages | Seed, Series A, Series B | Not enough dated deals |
| Sectors | Biotech | Not enough dated deals |
| Regions | Global | Not enough dated deals |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| Cure Ventures Fund I, L.P. | 2021 | $350.46M (Form D) | Follow-ons only |
03 · People across funds
- Dave Fallace, Managing Member of the General Partner
Cure Ventures Fund I, L.P. (Named on Form D)
- Louis Tartaglia, Managing Member of the General Partner
Cure Ventures Fund I, L.P. (Named on Form D)
- Richard Lim, Managing Member of the General Partner
Cure Ventures Fund I, L.P. (Named on Form D)
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
No news from the firm's website yet.
06 · Sources
- https://www.curevc.com/
- https://www.curevc.com/contact-us/
- https://www.curevc.com/companies/
- https://www.curevc.com/cure-ventures-launches-with-close-of-inaugural-350-million-dollar-fund/
- https://www.curevc.com/about-us/
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 25, 2026